NM_001018055.3:c.493-404C>T

Variant summary

Our verdict is Benign. The variant received -9 ACMG points: 0P and 9B. BP4_StrongBP6BS2

The NM_001018055.3(BRCC3):​c.493-404C>T variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00645 in 112,506 control chromosomes in the GnomAD database, including 3 homozygotes. There are 244 hemizygotes in GnomAD. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (no stars).

Frequency

Genomes: 𝑓 0.0065 ( 3 hom., 244 hem., cov: 23)

Consequence

BRCC3
NM_001018055.3 intron

Scores

2

Clinical Significance

Likely benign no assertion criteria provided B:1

Conservation

PhyloP100: -0.180

Publications

0 publications found
Variant links:
Genes affected
BRCC3 (HGNC:24185): (BRCA1/BRCA2-containing complex subunit 3) This gene encodes a subunit of the BRCA1-BRCA2-containing complex (BRCC), which is an E3 ubiquitin ligase. This complex plays a role in the DNA damage response, where it is responsible for the stable accumulation of BRCA1 at DNA break sites. The component encoded by this gene can specifically cleave Lys 63-linked polyubiquitin chains, and it regulates the abundance of these polyubiquitin chains in chromatin. The loss of this gene results in abnormal angiogenesis and is associated with syndromic moyamoya, a cerebrovascular angiopathy. Alternative splicing results in multiple transcript variants. A related pseudogene has been identified on chromosome 5. [provided by RefSeq, Jun 2011]
MTCP1 (HGNC:7423): (mature T cell proliferation 1) This gene was identified by involvement in some t(X;14) translocations associated with mature T-cell proliferations. This region has a complex gene structure, with a common promoter and 5' exon spliced to two different sets of 3' exons that encode two different proteins. This gene represents the upstream 13 kDa protein that is a member of the TCL1 family. This protein may be involved in leukemogenesis. [provided by RefSeq, Mar 2009]

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -9 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.6).
BP6
Variant X-155090380-C-T is Benign according to our data. Variant chrX-155090380-C-T is described in ClinVar as Likely_benign. ClinVar VariationId is 223596.Status of the report is no_assertion_criteria_provided, 0 stars.
BS2
High AC in GnomAd4 at 726 XL,AD gene.

Variant Effect in Transcripts

ACMG analysis was done for transcript: NM_001018055.3. You can select a different transcript below to see updated ACMG assignments.

RefSeq Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
BRCC3
NM_001018055.3
MANE Select
c.493-404C>T
intron
N/ANP_001018065.1P46736-2
BRCC3
NM_024332.4
c.493-404C>T
intron
N/ANP_077308.1P46736-1
BRCC3
NM_001242640.2
c.496-404C>T
intron
N/ANP_001229569.1P46736-3

Ensembl Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
BRCC3
ENST00000330045.12
TSL:1 MANE Select
c.493-404C>T
intron
N/AENSP00000328641.7P46736-2
BRCC3
ENST00000369462.5
TSL:1
c.493-404C>T
intron
N/AENSP00000358474.1P46736-1
BRCC3
ENST00000340647.8
TSL:2
c.496-404C>T
intron
N/AENSP00000344103.4P46736-3

Frequencies

GnomAD3 genomes
AF:
0.00646
AC:
726
AN:
112453
Hom.:
3
Cov.:
23
show subpopulations
Gnomad AFR
AF:
0.00123
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.00346
Gnomad ASJ
AF:
0.0215
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.000366
Gnomad FIN
AF:
0.0229
Gnomad MID
AF:
0.00840
Gnomad NFE
AF:
0.00828
Gnomad OTH
AF:
0.00656
We have no GnomAD4 exomes data on this position. Probably position not covered by the project.
GnomAD4 genome
AF:
0.00645
AC:
726
AN:
112506
Hom.:
3
Cov.:
23
AF XY:
0.00703
AC XY:
244
AN XY:
34718
show subpopulations
African (AFR)
AF:
0.00123
AC:
38
AN:
30997
American (AMR)
AF:
0.00346
AC:
37
AN:
10698
Ashkenazi Jewish (ASJ)
AF:
0.0215
AC:
57
AN:
2646
East Asian (EAS)
AF:
0.00
AC:
0
AN:
3603
South Asian (SAS)
AF:
0.000368
AC:
1
AN:
2721
European-Finnish (FIN)
AF:
0.0229
AC:
140
AN:
6110
Middle Eastern (MID)
AF:
0.00922
AC:
2
AN:
217
European-Non Finnish (NFE)
AF:
0.00828
AC:
441
AN:
53284
Other (OTH)
AF:
0.00648
AC:
10
AN:
1544
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.508
Heterozygous variant carriers
0
27
54
82
109
136
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
10
20
30
40
50
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.00751
Hom.:
47
Bravo
AF:
0.00566

ClinVar

ClinVar submissions
Significance:Likely benign
Revision:no assertion criteria provided
View on ClinVar
Pathogenic
VUS
Benign
Condition
-
-
1
Hereditary cancer-predisposing syndrome (1)

Computational scores

Source: dbNSFP v4.9

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.60
CADD
Benign
4.1
DANN
Benign
0.88
PhyloP100
-0.18
Mutation Taster
=100/0
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs184669955; hg19: chrX-154318655; API
For research and educational, non-commercial use only. Not for clinical or diagnostic use. GeneBe does not provide medical advice. Data use for AI modeling is prohibited: if used, the cost is $0.001 per byte of downloaded uncompressed data.